Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Namyang Dairy Products is a prominent South Korean company specializing in dairy-based nutritional products, including infant formula, milk, and functional beverages. Established in 1964, the company is a major player in the East Asian consumer healthcare and nutrition market, known for brands such as Imperial Dream XO and GT Milk. Beyond standard dairy, Namyang invests in research and development for functional food ingredients and specialized nutrition for infants and the elderly. In 2024, the company transitioned to new ownership under the private equity firm Hahn & Company following a high-profile legal dispute over management control. The company continues to focus on expanding its footprint in the global health and wellness sector through high-quality nutritional offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Namyang Dairy Products.